gemcitabine has been researched along with Gangrene in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, T; Ishikawa, S; Kanai, M; Kawaguchi, Y; Masui, T; Matsumoto, S; Mimori, T; Mori, Y; Nishimura, T; Yanagihara, K; Zaima, C | 1 |
| Clowse, ME; Wigley, FM | 1 |
| Genet, D; Labourey, JL; Ly, K; Martin, J; Szelag, JC; Tubiana-Mathieu, N; Vénat-Bouvet, L | 1 |
3 other study(ies) available for gemcitabine and Gangrene
| Article | Year |
|---|---|
A case of progressive digital ischemia after early withdrawal of gemcitabine and S-1 in a patient with systemic sclerosis.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Progression; Drug Administration Schedule; Drug Combinations; Fatal Outcome; Fingers; Gangrene; Gemcitabine; Humans; Ischemia; Male; Necrosis; Oxonic Acid; Pancreatic Neoplasms; Peritoneal Neoplasms; Raynaud Disease; Scleroderma, Systemic; Tegafur; Toes | 2011 |
Digital necrosis related to carboplatin and gemcitabine therapy in systemic sclerosis.
Topics: Antineoplastic Agents; Carboplatin; Deoxycytidine; Drug Therapy, Combination; Female; Fingers; Gangrene; Gemcitabine; Humans; Immunosuppressive Agents; Infarction; Middle Aged; Necrosis; Scleroderma, Systemic | 2003 |
Thrombotic microangiopathy and digital necrosis: two unrecognized toxicities of gemcitabine.
Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Fingers; Gangrene; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Iloprost; Male; Middle Aged; Pancreatic Neoplasms; Urinary Bladder Neoplasms; Vasodilator Agents | 2003 |